Does the media refer more to IDXX or NVST?

In the previous week, IDEXX Laboratories had 12 more articles in the media than Envista. MarketBeat recorded 16 mentions for IDEXX Laboratories and 4 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.06 beat Envista's score of 1.03 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IDXX or ISRG?

In the previous week, Intuitive Surgical had 11 more articles in the media than IDEXX Laboratories. MarketBeat recorded 27 mentions for Intuitive Surgical and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Intuitive Surgical's score of 0.68 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Intuitive Surgical 13 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IDXX or MDT?

In the previous week, Medtronic had 27 more articles in the media than IDEXX Laboratories. MarketBeat recorded 43 mentions for Medtronic and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Medtronic's score of 0.96 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 25 Very Positive mention(s) 7 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SYK or IDXX?

In the previous week, Stryker had 2 more articles in the media than IDEXX Laboratories. MarketBeat recorded 18 mentions for Stryker and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Stryker's score of 0.58 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Positive IDEXX Laboratories 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IDXX or BSX?

In the previous week, Boston Scientific had 7 more articles in the media than IDEXX Laboratories. MarketBeat recorded 23 mentions for Boston Scientific and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Boston Scientific's score of 0.31 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 10 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 9 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

IDEXX Laboratories (IDXX) Competitors

$510.73 +1.17 (+0.23%)

Closing price 04:00 PM Eastern

Extended Trading

$511.24 +0.51 (+0.10%)

As of 07:55 PM Eastern

Compare

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

Should you buy IDEXX Laboratories stock or one of its competitors? IDEXX Laboratories's main competitors and comparable companies include Envista (NVST), Intuitive Surgical (ISRG), Medtronic (MDT), Stryker (SYK), and Boston Scientific (BSX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does IDEXX Laboratories compare to Envista?

IDEXX Laboratories (NASDAQ:IDXX) and Envista (NYSE:NVST) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

IDEXX Laboratories has a net margin of 25.03% compared to Envista's net margin of 3.33%. IDEXX Laboratories' return on equity of 71.96% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Envista	3.33%	7.88%	4.33%

IDEXX Laboratories has a beta of 1.54, meaning that its share price is 54% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.35	$1.06B	$14.22	35.92
Envista	$2.72B	1.46	$47M	$0.58	42.68

In the previous week, IDEXX Laboratories had 12 more articles in the media than Envista. MarketBeat recorded 16 mentions for IDEXX Laboratories and 4 mentions for Envista. IDEXX Laboratories' average media sentiment score of 1.06 beat Envista's score of 1.03 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.8% of IDEXX Laboratories shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

IDEXX Laboratories presently has a consensus price target of $747.00, indicating a potential upside of 46.26%. Envista has a consensus price target of $29.71, indicating a potential upside of 20.03%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities analysts plainly believe IDEXX Laboratories is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envista	0 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.56

Summary

IDEXX Laboratories beats Envista on 13 of the 17 factors compared between the two stocks.

How does IDEXX Laboratories compare to Intuitive Surgical?

IDEXX Laboratories (NASDAQ:IDXX) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

IDEXX Laboratories currently has a consensus target price of $747.00, suggesting a potential upside of 46.26%. Intuitive Surgical has a consensus target price of $508.68, suggesting a potential upside of 34.87%. Given IDEXX Laboratories' higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Intuitive Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68

In the previous week, Intuitive Surgical had 11 more articles in the media than IDEXX Laboratories. MarketBeat recorded 27 mentions for Intuitive Surgical and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Intuitive Surgical's score of 0.68 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Intuitive Surgical	13 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.35	$1.06B	$14.22	35.92
Intuitive Surgical	$10.06B	13.24	$2.86B	$8.73	43.20

Intuitive Surgical has a net margin of 28.45% compared to IDEXX Laboratories' net margin of 25.03%. IDEXX Laboratories' return on equity of 71.96% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Intuitive Surgical	28.45%	16.91%	14.83%

Summary

IDEXX Laboratories and Intuitive Surgical tied by winning 8 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Medtronic?

IDEXX Laboratories (NASDAQ:IDXX) and Medtronic (NYSE:MDT) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

IDEXX Laboratories has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.35	$1.06B	$14.22	35.92
Medtronic	$36.36B	3.30	$4.80B	$4.06	23.09

In the previous week, Medtronic had 27 more articles in the media than IDEXX Laboratories. MarketBeat recorded 43 mentions for Medtronic and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Medtronic's score of 0.96 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	25 Very Positive mention(s)	7 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories currently has a consensus price target of $747.00, suggesting a potential upside of 46.26%. Medtronic has a consensus price target of $103.92, suggesting a potential upside of 10.87%. Given IDEXX Laboratories' higher probable upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Medtronic	0 Sell rating(s)	9 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.68

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by insiders. Comparatively, 0.3% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IDEXX Laboratories has a net margin of 25.03% compared to Medtronic's net margin of 13.93%. IDEXX Laboratories' return on equity of 71.96% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Medtronic	13.93%	14.78%	7.97%

Summary

IDEXX Laboratories beats Medtronic on 11 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Stryker?

Stryker (NYSE:SYK) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

In the previous week, Stryker had 2 more articles in the media than IDEXX Laboratories. MarketBeat recorded 18 mentions for Stryker and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Stryker's score of 0.58 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Positive
IDEXX Laboratories	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

77.1% of Stryker shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 4.6% of Stryker shares are held by company insiders. Comparatively, 0.8% of IDEXX Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Stryker presently has a consensus price target of $380.40, indicating a potential upside of 34.99%. IDEXX Laboratories has a consensus price target of $747.00, indicating a potential upside of 46.26%. Given IDEXX Laboratories' higher possible upside, analysts plainly believe IDEXX Laboratories is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	6 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.75
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Stryker has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market.

IDEXX Laboratories has a net margin of 25.03% compared to Stryker's net margin of 14.43%. IDEXX Laboratories' return on equity of 71.96% beat Stryker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	14.43%	23.63%	11.39%
IDEXX Laboratories	25.03%	71.96%	33.60%

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.12B	4.30	$3.25B	$9.65	29.20
IDEXX Laboratories	$4.30B	9.35	$1.06B	$14.22	35.92

Summary

IDEXX Laboratories beats Stryker on 10 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Boston Scientific?

IDEXX Laboratories (NASDAQ:IDXX) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

IDEXX Laboratories presently has a consensus target price of $747.00, indicating a potential upside of 46.26%. Boston Scientific has a consensus target price of $71.46, indicating a potential upside of 62.88%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Boston Scientific is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71

IDEXX Laboratories has a net margin of 25.03% compared to Boston Scientific's net margin of 17.50%. IDEXX Laboratories' return on equity of 71.96% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Boston Scientific	17.50%	19.28%	10.89%

IDEXX Laboratories has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Boston Scientific has higher revenue and earnings than IDEXX Laboratories. Boston Scientific is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.35	$1.06B	$14.22	35.92
Boston Scientific	$20.07B	3.17	$2.90B	$2.47	17.76

In the previous week, Boston Scientific had 7 more articles in the media than IDEXX Laboratories. MarketBeat recorded 23 mentions for Boston Scientific and 16 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.06 beat Boston Scientific's score of 0.31 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	10 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	9 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

IDEXX Laboratories beats Boston Scientific on 9 of the 16 factors compared between the two stocks.

Get IDEXX Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IDXX vs. The Competition

Export

Metric	IDEXX Laboratories	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$40.14B	$5.55B	$7.21B	$15.01B
Dividend Yield	N/A	1.79%	2.57%	12.21%
P/E Ratio	35.92	25.06	272.84	25.31
Price / Sales	9.35	72.21	651.75	87.56
Price / Cash	33.78	32.78	77.71	51.48
Price / Book	25.41	5.99	10.37	6.18
Net Income	$1.06B	$150.13M	$3.49B	$357.96M
7 Day Performance	-1.82%	-2.23%	-2.20%	-1.61%
1 Month Performance	-7.30%	-3.84%	-0.38%	-3.62%
1 Year Performance	-20.69%	10.26%	19.16%	5.95%

IDEXX Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IDXX IDEXX Laboratories	4.188 of 5 stars	$510.73 +0.2%	$747.00 +46.3%	-20.5%	$40.14B	$4.30B	35.92	11,000	Positive News
NVST Envista	3.406 of 5 stars	$27.12 -0.6%	$29.71 +9.6%	+22.5%	$4.38B	$2.72B	46.76	12,000	Positive News Gap Down
ISRG Intuitive Surgical	4.4698 of 5 stars	$366.70 flat	$508.68 +38.7%	-16.0%	$129.55B	$10.06B	42.00	17,021	Trending News Analyst Upgrade
MDT Medtronic	4.7795 of 5 stars	$94.12 -0.1%	$103.92 +10.4%	-0.2%	$120.46B	$36.36B	23.18	95,000	Trending News
SYK Stryker	4.9196 of 5 stars	$302.92 -0.1%	$386.28 +27.5%	-26.4%	$116.27B	$25.12B	31.39	56,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IDXX) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

How does IDEXX Laboratories compare to Envista?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Summary

How does IDEXX Laboratories compare to Medtronic?

Summary

How does IDEXX Laboratories compare to Stryker?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

How does IDEXX Laboratories compare to Envista?

Is IDXX or NVST more profitable?

Which has more volatility & risk, IDXX or NVST?

Which has preferable valuation and earnings, IDXX or NVST?

Does the media refer more to IDXX or NVST?

Do insiders & institutionals believe in IDXX or NVST?

Do analysts prefer IDXX or NVST?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Do institutionals & insiders have more ownership in IDXX or ISRG?

Do analysts prefer IDXX or ISRG?

Does the media favor IDXX or ISRG?

Which has more volatility and risk, IDXX or ISRG?

Which has preferable earnings and valuation, IDXX or ISRG?

Is IDXX or ISRG more profitable?

Summary

How does IDEXX Laboratories compare to Medtronic?

Which has more risk and volatility, IDXX or MDT?

Which has better valuation & earnings, IDXX or MDT?

Does the media favor IDXX or MDT?

Do analysts rate IDXX or MDT?

Do insiders and institutionals have more ownership in IDXX or MDT?

Is IDXX or MDT more profitable?

Summary

How does IDEXX Laboratories compare to Stryker?

Does the media refer more to SYK or IDXX?

Do insiders and institutionals believe in SYK or IDXX?

Do analysts prefer SYK or IDXX?

Which has more volatility and risk, SYK or IDXX?

Is SYK or IDXX more profitable?

Which has better earnings & valuation, SYK or IDXX?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Do analysts rate IDXX or BSX?

Is IDXX or BSX more profitable?

Which has more volatility and risk, IDXX or BSX?

Do insiders & institutionals believe in IDXX or BSX?

Which has better valuation and earnings, IDXX or BSX?

Does the media refer more to IDXX or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools